PPP2R3A was highly expressed in the high-risk group, indicating that these genes may be related to the oncology process for patients with PAAD, and they seemed to be cancer-promoting genes (Wu et al., 2022). Here, PPP2R3A is linked to pancreatic adenocarcinoma.